THIO/ALKOXY-SUBSTITUTED BENZOQUINONE DERIVATIVES
499
4,8-Dipropyl-3,4,9,10-tetrahydrobenzo[1,2-b:5,4-bꢁ]bis([1,4]oxathiepine)-6,12
(2H,8H)-dione (8): Compound 8 was synthesized from the reaction of 1 (0.5 g,
2.033 mmol) with 6 (0.84 mL, 6.01 mmol) according to the general procedure 1.
Black oil; Yield: 0.08 g (9%); Rf = 0.67 (ethyl acetate/petroleum ether 1:3); Anal.
Calcd. for C18H24O4S2: C, 58.67; H, 6.56; S, 17.40; Found: C, 59.01; H, 7.47; S,
17.24; IR (KBr, cm−1): ν = 2958, 2926, 2869 (C H), 1666, 1637 (C O), 1596, 1555
1
(C C). H NMR (499.74 MHz, CDCl3): δ = 4.4–4.8 (m, 4H, C O CH2), 3.5 (m, 4H,
OCH2 CH2 CH), 2.4 (m, 2H, CH2 CH S), 1.2, 1.4, 1.3, 1.7 (m, 8H, CH2), 0.8 ppm
(m, 6H, CH3-). 13C NMR (125.66 MHz, CDCl3): δ = 12.7 ( CH3), 19.1 ( CH2), 33.3
(SCH CH2), 36.1 (S CH), 44.2 (O CH2 CH2 CH), 70.4 (O CH2), 124.8 (C S),
151.8 ( C O), 172.9, 181.4 (C O) ppm. MS (m/z, (relative abundance,%)): 369 (M+H+,
100).
2,3,5,6-Tetrakis(1-hydroxyhexane-3-ylthio)cyclohexa-2,5-diene-1,4-dione (9):
Compound 9 was synthesized from the reaction of 1 (1 g, 4.066 mmol) with 6 (2.24 mL,
16.2 mmol) according to the general procedure 1.
Brown oil; Yield: 0.17 g (6%); Rf = 0.47 (ethylacetate); Anal. Calcd. for C30H52O6S4
:C, 56.57; H, 8.23; S, 20.14; Found: C, 57.07; H, 8.04; S, 18.02; IR (KBr, cm−1): ν = 3334
( OH), 2957, 2931, 2872 (C H), 1658 (C O), 1486, 1465 (C C). 1H NMR (499.74 MHz,
CDCl3): δ = 3.9, 3.8, 3.7, 3.6 (m, 8H, HO CH2), 1.9, 1.8 (m, 4H, S CH), 1.7, 1.6, 1.5,
1.3, 1.2 (m, 24H, CH2), 0.8 ppm (m, 12H, CH3-). 13C NMR (125.66 MHz, CDCl3):
δ = 12.9 ( CH3), 18.9 ( CH2 CH3), 38.4, 36.4 (SCH CH2), 45.8 (O CH2 CH2),
58.6 (O CH2), 145.8, 148.5, 149.7 (C S), 173.1 (C O) ppm. MS (m/z, (relative abun-
dance,%)): 636 (M−, 100).
2,3,5,6-Tetrakis(2-(pyrazin-2-yl)ethylthio)cyclohexa-2,5-diene-1,4-dione (10):
Compound 10 was synthesized from the reaction of 1 (0.5 g, 2.033 mmol) with 3 (1 mL g,
8.1 mmol) according to the general procedure 3.
Brown oil; Yield: 0.5 g (37%); Rf = 0.21 (EtOH); Anal. Calcd. for C30H28N8O2S4:
C, 54.52; H, 4.27; N, 16.96; S, 19.41; Found: C, 54.53; H, 4.15; N, 16.35; S, 20.15; IR (KBr,
cm−1): ν = 3069, 3050, 3005 (Ar H), 2926, 2837 (C H), 1653 (C O), 1634 (C C).
1H NMR (499.74 MHz, CDCl3): δ = 8.4 (m, 12H, CHarom), 3.4 (m, 8H, CH2-), 3.1 (m,
8H, S CH2) ppm. 13C NMR (125.66 MHz, CDCl3): δ = 33.4, 33.8, 35.1 (CH2), 124.7
( C S), 141.8, 142.7, 143.9, 144.4, 153.7 (N CHarom), 172.6 ppm (C O). MS (m/z,
(relative abundance,%)): 661 (M+H+, 100).
2,3,5-Tris(2-(pyrazin-2-yl)ethylthio)-6-cyclohexa-2,5-diene-1,4-dione (11): Com-
pound 11 was synthesized from the reaction of 1 (1 g, 4.066 mmol) with 3 (1.5 mL,
12.2 mmol) according to the general procedure 3.
Brown oil; Yield: 1.36 g (60%); Rf = 0.6 (ethylacetate); Anal. Calcd. for
C24H21ClN6O2S3: C, 51.74; H, 3.80; N, 15.09; S, 17.27; Found: C, 51.75; H, 3.35; N,
14.55; S, 16.26; IR (KBr, cm−1): ν = 3072, 3037 (Ar H), 2958, 2923, 2853 (C H), 1653
1
(C O), 1577, 1527 (C C). H NMR (499.74 MHz, CDCl3): δ = 8.4 (m, 9H, CHarom),
3.6, 3.5 (m, 6H, CH2-), 3.3, 3.2, 3.1, 3.0 ppm (m, 6H, S CH2). 13C NMR (125.66 MHz,
CDCl3): δ = 32.1, 33.5, 33.9, 34.9, 35.1 (CH2), 120.9 (C Cl), 122.3, 124.4, 126.4
( C S), 141.7, 143.1, 143.8, 153.8 (N CHarom), 173.6, 169.6 (C O) ppm. MS (m/z,
(relative abundance,%)): 556 (M−, 100).
A mixture of isomer compounds [2-(2-(pyrazin-2-yl)ethylthio)-3-Chloro-
5,6-diethoxycyclohexa-2,5-diene-1,4-dione (12a) and 2-(2-(pyrazin-2-yl)ethylthio)-
6-chloro-3,5-diethoxycyclohexa-2,5-diene-1,4-dione (12b)]: A mixture of isomer